Lyra TherapeuticsLYRA
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 51 institutions reported holding Lyra Therapeutics Inc. (LYRA) in their 13F filings, down 28 from Q1 2024. 13 opened new positions and 42 sold out. The largest holders were Perceptive Advisors LLC ($3.5M), Citadel Advisors ($1.3M) and BlackRock Inc. ($783K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Lyra Therapeutics Inc.
- CUSIP
- 55234L105
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $498K |
| Exits | 42 | $112.3M |
All 13F filers, Q1 2024 → Q2 2024: 7,439,864 shares bought and 20,280,673 shares sold, net −12,840,809 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 51 holders
| Perceptive Advisors LLC | 0.09% | No change | 12,757,562 | $3.5M |
| Citadel Advisors | 0.00% | Add +10.0% | 4,772,816 | $1.3M |
| BlackRock Inc. | 0.00% | Add +1762.8% | 2,829,978 | $783K |
| Samsara Biocapital, LLC | 0.16% | No change | 2,780,261 | $769K |
| Vanguard Group Inc. | 0.00% | Add +16.8% | 1,730,915 | $479K |
| Ikarian Capital, LLC | 0.09% | No change | 1,056,829 | $292K |
| Rosalind Advisors, Inc. | 0.23% | Reduce -9.6% | 1,034,773 | $286K |
| Acadian Asset Management LLC | 0.00% | New | 985,631 | $271K |
| Morgan Stanley | 0.00% | Add +1160.6% | 811,745 | $225K |
| Geode Capital Management, LLC | 0.00% | Add +110.1% | 755,095 | $209K |
| Two Sigma Advisers, LP | 0.00% | Add +373.7% | 681,600 | $189K |
| Two Sigma Investments, LP | 0.00% | Add +167.2% | 490,861 | $136K |
| New York State Common Retirement Fund | 0.00% | New | 382,900 | $106K |
| State Street Corp. | 0.00% | Add +105.9% | 259,820 | $72K |
| Boothbay Fund Management, LLC | 0.00% | No change | 232,670 | $64K |
| Simplex Trading, LLC | 0.00% | New | 129,141 | $35K |
| Clearline Capital LP | 0.00% | No change | 119,128 | $33K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 111,609 | $31K |
| Bank of America Corp. | 0.00% | Reduce -45.8% | 86,459 | $24K |
| Northern Trust Corp. | 0.00% | Add +38.6% | 83,860 | $23K |
| Bank of New York Mellon Corp | 0.00% | New | 77,423 | $21K |
| Alpine Global Management, LLC | 0.00% | New | 46,439 | $13K |
| Rhumbline Advisers | 0.00% | Add +14557.1% | 43,385 | $12K |
| Jane Street Group, LLC | 0.00% | Reduce -72.9% | 42,676 | $12K |
| Susquehanna International Group, LLP | 0.00% | Reduce -89.8% | 35,160 | $10K |
| XTX Topco Ltd | 0.00% | New | 33,951 | $9K |
| Alliancebernstein L.P. | 0.00% | New | 33,120 | $9K |
| Virtu Financial LLC | 0.00% | Add +165.7% | 31,690 | $9K |
| Letko, Brosseau & Associates Inc. | 0.00% | No change | 31,900 | $9K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | Add +34.0% | 27,516 | $8K |
| Corebridge Financial, Inc. | 0.00% | — | 26,036 | $7K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -92.7% | 24,391 | $7K |
| Invesco Ltd. | 0.00% | Reduce -95.9% | 22,824 | $6K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -88.8% | 21,471 | $6K |
| JPMorgan Chase & Co. | 0.00% | Reduce -81.1% | 20,659 | $6K |
| Millennium Management | 0.00% | Reduce -95.0% | 20,350 | $6K |
| Wells Fargo & Company | 0.00% | Add +6919.1% | 17,618 | $5K |
| Barclays PLC | 0.00% | Reduce -49.4% | 16,604 | $5K |
| UBS Group AG | 0.00% | Add +81550.0% | 14,697 | $4K |
| DLK Investment Management, LLC | 0.00% | No change | 12,000 | $3K |
| Citigroup Inc. | 0.00% | Reduce -91.0% | 10,652 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -23.5% | 6,822 | $2K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 4,741 | $1K |
| National Bank of Canada | 0.00% | No change | 3,700 | $1K |
| Royal Bank of Canada | 0.00% | Add +645.1% | 4,873 | $1K |
| California State Teachers Retirement System | 0.00% | New | 3,507 | $970 |
| Osaic Holdings, Inc. | 0.00% | Reduce -31.1% | 1,378 | $383 |
| Comerica Bank | 0.00% | No change | 1,159 | $321 |
| Farther Finance Advisors, LLC | 0.00% | New | 38 | $11 |
| T. Rowe Price Associates Inc. | 0.00% | New | 17,541 | $0 |
| Amalgamated Bank | 0.00% | New | 1,674 | $0 |
"% of holder's portfolio" is LYRA's weight in each manager's 13F, not the share of Lyra Therapeutics Inc. the manager owns.